US Patent Issued to SMT BIO, INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY on Sept. 29 for "Chimeric antigen receptor for treatment of cancer" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,278, issued on Sept. 29, was assigned to SMT BIO Co. LTD. (Seoul, South Korea) and INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (Seoul, South Korea).

"Chimeric antigen receptor for treatment of cancer" was invented by Yong Yoon Chung (Seoul, South Korea) and In Hye Jung (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel chimeric antigen receptor and to a pharmaceutical composition for preventing or treating containing the same."

The patent was filed on May 7, 2021, under Application No. 17/998,233.

*For further information, including images, charts and tables, please visit: h...